Kristensen Niels Rode, Madsen Henrik, Ingwersen Steen Hvass
Pharmacokinetics and Biomodelling, Novo Nordisk A/S, Novo Nordisk Park, DK-22760, Målov, Denmark.
J Pharmacokinet Pharmacodyn. 2005 Feb;32(1):109-41. doi: 10.1007/s10928-005-2105-9.
A method for PK/PD model development based on stochastic differential equation models is proposed. The new method has a number of advantages compared to conventional methods. In particular, the new method avoids the exhaustive trial-and-error based search often conducted to determine the most appropriate model structure, because it allows information about the appropriate model structure to be extracted directly from data. This is accomplished through quantification of the uncertainty of the individual parts of an initial model, by means of which tools for performing model diagnostics can be constructed and guidelines for model improvement provided. Furthermore, the new method allows time-variations in key parameters to be tracked and visualized graphically, which allows important functional relationships to be revealed. Using simulated data, the performance of the new method is demonstrated by means of two examples. The first example shows how, starting from a simple assumption of linear PK, the method can be used to determine the correct nonlinear model for describing the PK of a drug following an oral dose. The second example shows how, starting from a simple assumption of no drug effect, the method can be used to determine the correct model for the nonlinear effect of a drug with known PK in an indirect response model.
提出了一种基于随机微分方程模型的药代动力学/药效学(PK/PD)模型开发方法。与传统方法相比,新方法具有许多优点。特别是,新方法避免了通常为确定最合适的模型结构而进行的详尽的试错搜索,因为它允许直接从数据中提取有关合适模型结构的信息。这是通过量化初始模型各个部分的不确定性来实现的,借此可以构建模型诊断工具并提供模型改进指南。此外,新方法允许跟踪关键参数随时间的变化并以图形方式进行可视化,从而揭示重要的功能关系。通过两个示例,利用模拟数据展示了新方法的性能。第一个示例展示了如何从线性药代动力学的简单假设出发,使用该方法确定描述口服给药后药物药代动力学的正确非线性模型。第二个示例展示了如何从无药物效应的简单假设出发,使用该方法在间接响应模型中确定具有已知药代动力学的药物非线性效应的正确模型。